RI
FULC icon

RTW Investments’s Fulcrum Therapeutics FULC Stock Holding History

RTW Investments’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,845,956
Closed -$36.2M – 71
2024
Q2 		$36.2M Hold
5,845,956
– – 0.56% 41
2024
Q1 		$55.2M Buy
5,845,956
+376,000
+7% +$3.36M 0.81% 37
2023
Q4 		$36.9M Sell
5,469,956
-348,848
-6% -$1.55M 0.58% 35
2023
Q3 		$25.8M Sell
5,818,804
-245,319
-4% -$1.07M 0.55% 33
2023
Q2 		$20M Buy
6,064,123
+552,284
+10% +$1.62M 0.38% 38
2023
Q1 		$15.7M Buy
5,511,839
+518,560
+10% +$4.65M 0.33% 35
2022
Q4 		$36.4M Buy
4,993,279
+1,007,369
+25% +$6.57M 0.74% 32
2022
Q3 		$32.2M Buy
3,985,910
+24,716
+0.6% +$177K 0.74% 36
2022
Q2 		$19.4M Buy
3,961,194
+350,000
+10% +$3.42M 0.5% 44
2022
Q1 		$85.4M Sell
3,611,194
-255,678
-7% -$3.62M 1.77% 23
2021
Q4 		$68.4M Buy
3,866,872
+11,581
+0.3% +$229K 1% 31
2021
Q3 		$109M Buy
3,855,291
+650,000
+20% +$12.3M 1.64% 21
2021
Q2 		$33.6M Hold
3,205,291
– – 0.51% 50
2021
Q1 		$37.8M Buy
3,205,291
+1,133,882
+55% +$14M 0.59% 48
2020
Q4 		$24.3M Buy
2,071,409
+920,844
+80% +$10.4M 0.41% 53
2020
Q3 		$9.12M Buy
+1,150,565
New +$13.9M 0.22% 67

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RTW Investments's FULC Position: Q3 2024 in Review

RTW Investments sold out of Fulcrum Therapeutics (FULC) in Q3 2024, closing a stake of 5,845,956 shares — an estimated $36.2M sold.

RTW Investments first reported a position in FULC in Q3 2020 and held it in 16 quarters. The position peaked at $109M in Q3 2021. 130 funds tracked by Wall St. Rank hold FULC as of Q3 2024.

  • RTW Investments reported no remaining Fulcrum Therapeutics position as of Q3 2024 after selling out during the quarter.
  • RTW Investments sold 5,845,956 Fulcrum Therapeutics shares in Q3 2024, an estimated $36.2M.
  • RTW Investments first reported a position in Fulcrum Therapeutics in Q3 2020 and held it in 16 quarters.
  • RTW Investments's Fulcrum Therapeutics position peaked at $109M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2024.

Based on RTW Investments's 13F filing for Q3 2024, filed 14 Nov 2024.